+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Very Late In-Stent Restenosis in a Bare Metal Stent

      , , ,


      S. Karger AG

      Late restenosis, Bare metal stent

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Restenosis after coronary artery stenting is a common phenomenon and represents a topic of great interest. Although a great volume of research is referring to restenosis, still many issues are not fully understood by the cardiological community. Here we present a case of very late restenosis, after a bare metal stent implantation.

          Related collections

          Most cited references 2

          • Record: found
          • Abstract: found
          • Article: not found

          Drug eluting stents: are human and animal studies comparable?

          Animal models of stenting probably predict human responses as the stages of healing are remarkably similar. What is characteristically different is the temporal response to healing, which is substantially prolonged in humans. The prevention of restenosis in recent clinical trials of drug eluting stents may represent a near absent or incomplete phase of intimal healing. Continued long term follow up of patients with drug eluting stents for major adverse cardiac events and angiographic restenosis is therefore imperative.
            • Record: found
            • Abstract: found
            • Article: found

            ‘Give Time a Chance’ for In-Stent Restenosis Regression


              Author and article information

              S. Karger AG
              May 2007
              02 February 2007
              : 107
              : 4
              : 360-361
              Second Cardiology Department, Red Cross General Hospital, Athens, Greece
              99051 Cardiology 2007;107:360–361
              © 2007 S. Karger AG, Basel

              Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

              Page count
              Figures: 1, References: 2, Pages: 2
              Case Report


              Comment on this article